COMPASS Pathways plc (CMPS) Discusses Positive Phase III Results for COMP360 in Treatment-Resistant Depression Trials Transcript

Group 1 - The webinar is hosted by Stephen Schultz, Senior Vice President of Investor Relations for COMPASS Pathways [2] - The call is being recorded, indicating a formal update on the company's status [1] - Forward-looking statements will be made during the call, which are subject to risks and uncertainties [3]